Balawag, Alcher Jhon M.
HRN: 21-93-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/27/2022
IV
1.5g
Q8H
Fracture, Multiple Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes